Antidiabetic Action of Bezafibrate in a Large Observational Database

Abstract

Bezafibrate appears to have clinically important antidiabetic properties. Randomized controlled trials should be considered to assess the utility of bezafibrate in treating patients with diabetes or in preventing diabetes in high-risk patients.